SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-18-013884
Filing Date
2018-10-15
Accepted
2018-10-15 07:00:39
Documents
3
Period of Report
2018-10-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k101518_soligenixinc.htm 8-K 29547
2 PRESS RELEASE ISSUED BY THE COMPANY ON OCTOBER 15, 2018 f8k101518ex99-1_soligenixinc.htm EX-99.1 19495
3 GRAPHIC ex99-1_001.jpg GRAPHIC 21870
  Complete submission text file 0001213900-18-013884.txt   80679
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14778 | Film No.: 181121287
SIC: 2834 Pharmaceutical Preparations